1. Elite Intelligence & Strategic Foresight

We don't just consult; we provide actionable foresight. By deeply analyzing mechanistic data, target biology, and competitive landscapes, we help biotech founders and institutional investors de-risk early-stage pipelines and identify high-value therapeutic targets before making critical capital allocations.

Focus: De-risking early-stage pipelines, mechanistic data analysis, and competitive landscape mapping for biotech founders and institutional investors.

Tier 1: Asset Target Verification Sprint

What they get: A concentrated advisory audit of a single therapeutic target or biological mechanism. Includes a mechanistic viability report and a high-level overview of the immediate competitive landscape.

Pricing: $150/h (Custom pricing upon consultation).

Tier 2: Pipeline Intelligence & De-Risking Assessment (Project Fee)

What they get: Comprehensive deep-dive analysis of an early-stage multi-asset pipeline. Includes target biology validation, rigorous mapping of competitive IP, and an analytical risk matrix to guide critical capital allocation before a funding round.

Pricing: Depending on pipeline complexity.

Tier 3: Elite Intelligence & Institutional Advisory Foresight (Bespoke/Retainer)

What they get: Ongoing, continuous strategic foresight for venture capital firms or cross-disciplinary biotech portfolios. Provides active advisory presence during due diligence, real-time pipeline stress-testing, and dynamic target identification.

Pricing: Custom Retainer Model (Custom pricing upon consultation).